Back to Search
DANIEL REARDON, M.D.
M.D.
Surgery Physician
NPI: 1265431357Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
PMID 19248046·Cancer·2009
3-trial
Oesophageal dilatation due to a paraoesophageal hernia and gastric volvulus as a cause of stridor.
PMID 17901285·Emerg Med J·2007
5-case
Relative treatment rates for sleep disorders and sleep disturbances following abortion and childbirth: a prospective record-based study.
PMID 16453987·Sleep·2006
8-other
Substance use associated with unintended pregnancy outcomes in the National Longitudinal Survey of Youth.
PMID 15230081·Am J Drug Alcohol Abuse·2004
8-other
Psychiatric admissions of low-income women following abortion and childbirth.
PMID 12743066·CMAJ·2003
8-other
Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study.
PMID 11799033·BMJ·2002
8-other
Deaths associated with pregnancy outcome: a record linkage study of low income women.
PMID 12190217·South Med J·2002
8-other
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing.
PMID 19212703·J Neurooncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 390 TOLL GATE RD, STE.200
WARWICK, RI 02886 - Phone
- (401) 691-3300
Quick Facts
- NPI
- 1265431357
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile